Elucidation of metabolic pathways of 25-hydroxyvitamin D3 mediated by CYP24A1 and CYP3A using Cyp24a1 knockout rats generated by CRISPR/Cas9 system
CYP24A1-deficient (Cyp24a1 KO) rats were generated using the CRISPER/Cas9 system to investigate CYP24A1-dependent or -independent metabolism of 25(OH)D3, the prohormone of calcitriol. Plasma 25(OH)D3 concentrations in Cyp24a1 KO rats were approximately twofold higher than in wild-type rats. Wild-typ...
Saved in:
Published in | The Journal of biological chemistry Vol. 296; p. 100668 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.01.2021
American Society for Biochemistry and Molecular Biology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | CYP24A1-deficient (Cyp24a1 KO) rats were generated using the CRISPER/Cas9 system to investigate CYP24A1-dependent or -independent metabolism of 25(OH)D3, the prohormone of calcitriol. Plasma 25(OH)D3 concentrations in Cyp24a1 KO rats were approximately twofold higher than in wild-type rats. Wild-type rats showed five metabolites of 25(OH)D3 in plasma following oral administration of 25(OH)D3, and these metabolites were not detected in Cyp24a1 KO rats. Among these metabolites, 25(OH)D3-26,23-lactone was identified as the second major metabolite with a significantly higher Tmax value than others. When 23S,25(OH)2D3 was administered to Cyp24a1 KO rats, neither 23,25,26(OH)3D3 nor 25(OH)D3-26,23-lactone was observed. However, when 23S,25R,26(OH)3D3 was administered to Cyp24a1 KO rats, plasma 25(OH)D3-26,23-lactone was detected. These results suggested that CYP24A1 is responsible for the conversion of 25(OH)D3 to 23,25,26(OH)3D3 via 23,25(OH)2D3, but enzyme(s) other than CYP24A1 may be involved in the conversion of 23,25,26(OH)3D3 to 25(OH)D3-26,23-lactone. Enzymatic studies using recombinant human CYP species and the inhibitory effects of ketoconazole suggested that CYP3A plays an essential role in the conversion of 23,25,26(OH)3D3 into 25(OH)D3-26,23-lactone in both rats and humans. Taken together, our data indicate that Cyp24a1 KO rats are valuable for metabolic studies of vitamin D and its analogs. In addition, long-term administration of 25(OH)D3 to Cyp24a1 KO rats at 110 μg/kg body weight/day resulted in significant weight loss and ectopic calcification. Thus, Cyp24a1 KO rats could represent an important model for studying renal diseases originating from CYP24A1 dysfunction. |
---|---|
AbstractList | CYP24A1-deficient (Cyp24a1 KO) rats were generated using the CRISPER/Cas9 system to investigate CYP24A1-dependent or -independent metabolism of 25(OH)D3, the prohormone of calcitriol. Plasma 25(OH)D3 concentrations in Cyp24a1 KO rats were approximately twofold higher than in wild-type rats. Wild-type rats showed five metabolites of 25(OH)D3 in plasma following oral administration of 25(OH)D3, and these metabolites were not detected in Cyp24a1 KO rats. Among these metabolites, 25(OH)D3-26,23-lactone was identified as the second major metabolite with a significantly higher Tmax value than others. When 23S,25(OH)2D3 was administered to Cyp24a1 KO rats, neither 23,25,26(OH)3D3 nor 25(OH)D3-26,23-lactone was observed. However, when 23S,25R,26(OH)3D3 was administered to Cyp24a1 KO rats, plasma 25(OH)D3-26,23-lactone was detected. These results suggested that CYP24A1 is responsible for the conversion of 25(OH)D3 to 23,25,26(OH)3D3 via 23,25(OH)2D3, but enzyme(s) other than CYP24A1 may be involved in the conversion of 23,25,26(OH)3D3 to 25(OH)D3-26,23-lactone. Enzymatic studies using recombinant human CYP species and the inhibitory effects of ketoconazole suggested that CYP3A plays an essential role in the conversion of 23,25,26(OH)3D3 into 25(OH)D3-26,23-lactone in both rats and humans. Taken together, our data indicate that Cyp24a1 KO rats are valuable for metabolic studies of vitamin D and its analogs. In addition, long-term administration of 25(OH)D3 to Cyp24a1 KO rats at 110 μg/kg body weight/day resulted in significant weight loss and ectopic calcification. Thus, Cyp24a1 KO rats could represent an important model for studying renal diseases originating from CYP24A1 dysfunction. CYP24A1-deficient (Cyp24a1 KO) rats were generated using the CRISPER/Cas9 system to investigate CYP24A1-dependent or -independent metabolism of 25(OH)D3, the prohormone of calcitriol. Plasma 25(OH)D3 concentrations in Cyp24a1 KO rats were approximately two-fold higher than in wild-type rats. Wild-type rats showed five metabolites of 25(OH)D3 in plasma following oral administration of 25(OH)D3, and these metabolites were not detected in Cyp24a1 KO rats. Among these metabolites, 25(OH)D3-26,23-lactone was identified as the second major metabolite with a significantly higher T value than others. When 23S,25(OH) D3 was administered to Cyp24a1 KO rats, neither 23,25,26(OH) D3 nor 25(OH)D3-26,23-lactone were observed. However, when 23S,25R,26(OH) D3 was administered to Cyp24a1 KO rats, plasma 25(OH)D3-26,23-lactone was detected. These results suggested that CYP24A1 is responsible for the conversion of 25(OH)D3 to 23,25,26(OH) D3 via 23,25(OH) D3, but enzyme(s) other than CYP24A1 may be involved in the conversion of 23,25,26(OH) D3 to 25(OH)D3-26,23-lactone. Enzymatic studies using recombinant human CYP species and the inhibitory effects of ketoconazole suggested that CYP3A plays an essential role in the conversion of 23,25,26(OH) D3 into 25(OH)D3-26,23-lactone in both rats and humans. Taken together, our data indicate that Cyp24a1 KO rats are valuable for metabolic studies of vitamin D and its analogs. In addition, long-term administration of 25(OH)D3 to Cyp24a1 KO rats at 110 μg/kg body weight/day resulted in significant weight loss and ectopic calcification. Thus, Cyp24a1 KO rats could represent an important model for studying renal diseases originating from CYP24A1 dysfunction. CYP24A1-deficient ( Cyp24a1 KO) rats were generated using the CRISPER/Cas9 system to investigate CYP24A1-dependent or -independent metabolism of 25(OH)D3, the prohormone of calcitriol. Plasma 25(OH)D3 concentrations in Cyp24a1 KO rats were approximately twofold higher than in wild-type rats. Wild-type rats showed five metabolites of 25(OH)D3 in plasma following oral administration of 25(OH)D3, and these metabolites were not detected in Cyp24a1 KO rats. Among these metabolites, 25(OH)D3-26,23-lactone was identified as the second major metabolite with a significantly higher T max value than others. When 23 S ,25(OH) 2 D3 was administered to Cyp24a1 KO rats, neither 23,25,26(OH) 3 D3 nor 25(OH)D3-26,23-lactone was observed. However, when 23 S ,25 R ,26(OH) 3 D3 was administered to Cyp24a1 KO rats, plasma 25(OH)D3-26,23-lactone was detected. These results suggested that CYP24A1 is responsible for the conversion of 25(OH)D3 to 23,25,26(OH) 3 D3 via 23,25(OH) 2 D3, but enzyme(s) other than CYP24A1 may be involved in the conversion of 23,25,26(OH) 3 D3 to 25(OH)D3-26,23-lactone. Enzymatic studies using recombinant human CYP species and the inhibitory effects of ketoconazole suggested that CYP3A plays an essential role in the conversion of 23,25,26(OH) 3 D3 into 25(OH)D3-26,23-lactone in both rats and humans. Taken together, our data indicate that Cyp24a1 KO rats are valuable for metabolic studies of vitamin D and its analogs. In addition, long-term administration of 25(OH)D3 to Cyp24a1 KO rats at 110 μg/kg body weight/day resulted in significant weight loss and ectopic calcification. Thus, Cyp24a1 KO rats could represent an important model for studying renal diseases originating from CYP24A1 dysfunction. |
ArticleNumber | 100668 |
Author | Tsugawa, Naoko Kawagoe, Fumihiro Mano, Hiroki Okano, Toshio Yasuda, Kaori Okon, Risa Okamoto, Kairi Horibe, Kyohei Sakaki, Toshiyuki Nishikawa, Miyu Yamaguchi, Mana Ikushiro, Shinichi Nakagawa, Kimie Kittaka, Atsushi |
Author_xml | – sequence: 1 givenname: Kaori orcidid: 0000-0003-3495-3216 surname: Yasuda fullname: Yasuda, Kaori organization: Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan – sequence: 2 givenname: Miyu surname: Nishikawa fullname: Nishikawa, Miyu organization: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan – sequence: 3 givenname: Kairi surname: Okamoto fullname: Okamoto, Kairi organization: Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan – sequence: 4 givenname: Kyohei surname: Horibe fullname: Horibe, Kyohei organization: Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan – sequence: 5 givenname: Hiroki surname: Mano fullname: Mano, Hiroki organization: Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan – sequence: 6 givenname: Mana surname: Yamaguchi fullname: Yamaguchi, Mana organization: Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan – sequence: 7 givenname: Risa surname: Okon fullname: Okon, Risa organization: Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan – sequence: 8 givenname: Kimie surname: Nakagawa fullname: Nakagawa, Kimie organization: Laboratory of Hygienic Sciences, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Chuo-ku, Kobe, Japan – sequence: 9 givenname: Naoko surname: Tsugawa fullname: Tsugawa, Naoko organization: Department of Health and Nutrition, Faculty of Health and Nutrition, Osaka Shoin Women's University, Higashi-Osaka, Japan – sequence: 10 givenname: Toshio surname: Okano fullname: Okano, Toshio organization: Department of Hygienic Sciences, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Japan – sequence: 11 givenname: Fumihiro surname: Kawagoe fullname: Kawagoe, Fumihiro organization: Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo, Japan – sequence: 12 givenname: Atsushi surname: Kittaka fullname: Kittaka, Atsushi organization: Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo, Japan – sequence: 13 givenname: Shinichi surname: Ikushiro fullname: Ikushiro, Shinichi organization: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan – sequence: 14 givenname: Toshiyuki surname: Sakaki fullname: Sakaki, Toshiyuki email: tsakaki@pu-toyama.ac.jp organization: Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33865853$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctuEzEUhi1URNPCA7BBXrKZ1JfxXISEFA2lVKpEVUCCleXxnEmcTuzU9gTmOfrCOEqJYIM39vH5_9-X7wydWGcBodeUzCmhxcV6vm71nBFGU02KonqGZpRUPOOCfj9BM5I6Wc1EdYrOQliTNPKavkCnnFeFqASfocfLYdSmU9E4i12PNxBV6waj8VbF1U81hf0uE9lq6rz7Ne1MVBtj8QeepJ1RETrcTrj5ccvyBcXKdvs1X-AxGLvEzbRluaL43jp978aIvYoBL8GCP1rvrr_c3l00KtQ4TCHC5iV63qshwKun-Rx9-3j5tfmU3Xy-um4WN5kWtIwZAOM5qEJrEAp0yVnbFq2mmvG2K1sNPa2LShBRqZ7nWhelFj3LK9rlpSaV4ufo_SF3O7bpMRps9GqQW282yk_SKSP_7Vizkku3kxXlOSlZCnj7FODdwwghyo0JGoZBWXBjkExQQYq8qEmS0oNUexeCh_54DCVyD1OuZYIp9zDlAWbyvPn7fkfHH3pJ8O4ggPRLOwNeBm3A6gTGg46yc-Y_8b8ByR2ykA |
CitedBy_id | crossref_primary_10_3390_molecules27165352 crossref_primary_10_1248_cpb_c23_00395 crossref_primary_10_3390_ijms22158191 crossref_primary_10_3390_biom14060717 crossref_primary_10_3390_biom11111639 crossref_primary_10_1371_journal_ppat_1009986 crossref_primary_10_3390_ijms222111863 crossref_primary_10_1007_s00795_024_00387_y crossref_primary_10_1016_j_bcp_2024_116231 crossref_primary_10_1021_acs_joc_3c01134 crossref_primary_10_3390_ijms23052548 crossref_primary_10_3390_biom14010037 crossref_primary_10_17816_clinutr115028 crossref_primary_10_3390_ijms222111839 crossref_primary_10_7554_eLife_75419 |
Cites_doi | 10.1016/0014-5793(82)80867-3 10.1016/S8756-3282(99)00118-0 10.1210/endo.141.7.7579 10.1016/j.abb.2011.11.003 10.1016/0022-4731(86)90395-X 10.1016/j.jsbmb.2018.07.012 10.1111/febs.12862 10.1073/pnas.0702093104 10.1016/0014-5793(81)80603-5 10.1007/s13353-017-0397-2 10.1046/j.1432-1327.2000.01680.x 10.1248/bpb.28.646 10.2215/CJN.05360512 10.1056/NEJMoa1103864 10.1016/j.jsbmb.2018.02.001 10.1042/bj2500527 10.1016/S0076-6879(05)00010-8 10.1248/bpb.24.738 10.1016/j.jsbmb.2018.10.010 10.1016/S0021-9258(18)34119-X 10.1172/JCI98680 10.1210/en.2004-1116 10.1210/en.2015-1664 10.1210/jc.2013-4388 10.1016/j.apsb.2019.03.005 10.1073/pnas.77.11.6411 10.1038/s41598-020-62048-1 10.1016/j.jsbmb.2018.12.001 10.1124/dmd.117.078428 10.1210/en.2013-2013 10.1016/S0021-9258(18)48219-1 10.1002/jbmr.3135 10.1016/j.bbrc.2004.07.040 |
ContentType | Journal Article |
Copyright | 2021 The Authors Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. 2021 The Authors 2021 |
Copyright_xml | – notice: 2021 The Authors – notice: Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. – notice: 2021 The Authors 2021 |
DBID | 6I. AAFTH NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1016/j.jbc.2021.100668 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1083-351X |
EndPage | 100668 |
ExternalDocumentID | 10_1016_j_jbc_2021_100668 33865853 S0021925821004579 |
Genre | Journal Article |
GroupedDBID | --- -DZ -ET -~X .55 .GJ 0SF 186 18M 29J 2WC 34G 39C 3O- 4.4 41~ 53G 5BI 5GY 5RE 5VS 6I. 6TJ 79B 85S AAEDW AAFTH AAFWJ AARDX AAXUO AAYJJ AAYOK ABDNZ ABFSI ABOCM ABPPZ ABRJW ABTAH ACGFO ACNCT ACSFO ACYGS ADBBV ADIYS ADNWM AENEX AEXQZ AFDAS AFFNX AFMIJ AFOSN AFPKN AHPSJ AI. ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BTFSW C1A CJ0 CS3 DIK DU5 E.L E3Z EBS EJD F20 F5P FA8 FDB FRP GROUPED_DOAJ GX1 HH5 HYE IH2 J5H KQ8 L7B MVM N9A NHB OHT OK1 P-O P0W P2P QZG R.V RHF RHI RNS ROL RPM SJN TBC TN5 TR2 UHB UKR UPT UQL VH1 VQA W8F WH7 WHG WOQ X7M XFK XJT XSW Y6R YQT YSK YWH YYP YZZ ZA5 ZE2 ZGI ZY4 ~02 ~KM 0R~ AALRI ADVLN AITUG AKRWK NPM AAYXX CITATION H13 7X8 5PM |
ID | FETCH-LOGICAL-c517t-ee234ea6cce5aec732bb6bc1c23bd7bcef19685058af34cc67c5f2481d47c08a3 |
IEDL.DBID | RPM |
ISSN | 0021-9258 |
IngestDate | Tue Sep 17 21:17:12 EDT 2024 Fri Oct 25 03:19:12 EDT 2024 Fri Aug 23 04:02:27 EDT 2024 Sat Sep 28 08:28:53 EDT 2024 Fri Feb 23 02:43:02 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | CYP24A1 CRISPR/Cas9 ADX PTH VDR vitamin D 1,25(OH)2D3 metabolism cytochrome P450 25(OH)D3 ADR |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c517t-ee234ea6cce5aec732bb6bc1c23bd7bcef19685058af34cc67c5f2481d47c08a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3495-3216 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134072/ |
PMID | 33865853 |
PQID | 2515064690 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8134072 proquest_miscellaneous_2515064690 crossref_primary_10_1016_j_jbc_2021_100668 pubmed_primary_33865853 elsevier_sciencedirect_doi_10_1016_j_jbc_2021_100668 |
PublicationCentury | 2000 |
PublicationDate | 2021-01-01 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of biological chemistry |
PublicationTitleAlternate | J Biol Chem |
PublicationYear | 2021 |
Publisher | Elsevier Inc American Society for Biochemistry and Molecular Biology |
Publisher_xml | – name: Elsevier Inc – name: American Society for Biochemistry and Molecular Biology |
References | Bouillon, Okamura, Norman (bib22) 1995; 16 Masuda, Byford, Arabian, Sakai, Demay, St-Arnaud, Jones (bib12) 2005; 146 Kaufmann, Gallagher, Peacock, Schlingmann, Konrad, DeLuca, Sigueiro, Lopez, Mourino, Maestro, St-Arnaud, Finkelstein, Cooper, Jones (bib16) 2014; 99 Kaufmann, Morse, Molloy, Cooper, Schlingmann, Molin, Kottler, Gallagher, Armas, Jones (bib15) 2017; 32 Kusudo, Sakaki, Abe, Fujishima, Kittaka, Takayama, Hatakeyama, Ohta, Inouye (bib6) 2004; 321 Ishizuka, Yamaguchi, Yamada, Nakayama, Takayama (bib19) 1981; 134 Kawagoe, Sugiyama, Yasuda, Uesugi, Sakaki, Kittaka (bib33) 2019; 186 Higashi, Awada, Shimada (bib20) 2001; 24 Chatterjee, Echchgadda, Song (bib30) 2005; 400 Tieu, Tang, Tuckey (bib35) 2014; 281 Pedersen, Hagenfeldt, Bjorkhem (bib7) 1988; 250 Yasuda, Tohyama, Takano, Kittaka, Ohta, Ikushiro, Sakaki (bib34) 2018; 178 Jones, Prosser, Kaufmann (bib1) 2012; 523 Nishikawa, Yasuda, Takamatsu, Abe, Okamoto, Horibe, Mano, Nakagawa, Tsugawa, Hirota, Horie, Hinoi, Okano, Ikushiro, Sakaki (bib17) 2020; 10 Prosser, Kaufmann, O'Leary, Byford, Jones (bib8) 2007; 104 Nishikawa, Yasuda, Takamatsu, Abe, Nakagawa, Tsugawa, Hirota, Tanaka, Yamashita, Ikushiro, Suda, Okano, Sakaki (bib11) 2019; 185 Kaufmann, Lee, Pike, Jones (bib14) 2015; 156 St-Arnaud (bib21) 1999; 25 Ishizuka, Norman (bib23) 1987; 262 Kaufmann, Martineau, Arabian, Traynor, St-Arnaud, Jones (bib13) 2019; 188 St-Arnaud, Arabian, Travers, Barletta, Raval-Pandya, Chapin, Depovere, Mathieu, Christakos, Demay, Glorieux (bib32) 2000; 141 Schlingmann, Kaufmann, Weber, Irwin, Goos, John, Misselwitz, Klaus, Kuwertz-Broking, Fehrenbach, Wingen, Guran, Hoenderop, Bindels, Prosser (bib4) 2011; 365 Ishizuka, Norman (bib26) 1986; 25 Sakaki, Sawada, Komai, Shiozawa, Yamada, Yamamoto, Ohyama, Inouye (bib5) 2000; 267 Qin, Wang (bib29) 2019; 9 Napoli, Pramanik, Partridge, Uskokovic, Horst (bib9) 1982; 257 Pronicka, Ciara, Halat, Janiec, Wojcik, Rowinska, Rokicki, Pludowski, Wojciechowska, Wierzbicka, Ksiazyk, Jacoszek, Konrad, Schlingmann, Litwin (bib31) 2017; 58 Ishizuka, Ishimoto, Norman (bib18) 1982; 139 Matsunaga, Higuchi, Watanabe, Kageyama, Ohmori, Yamamoto (bib24) 2005; 28 Wong, Wang, Chapron, Suzuki, Claw, Gao, Foti, Prasad, Chapron, Calamia, Chaudhry, Schuetz, Horst, Mao, de Boer (bib27) 2018; 46 Wang, Wong, Hashizume, Dickmann, Scian, Koszewski, Goff, Horst, Chaudhry, Schuetz, Thummel (bib28) 2014; 155 Sakaki, Kagawa, Yamamoto, Inouye (bib2) 2005; 10 Roizen, Li, O'Lear, Javaid, Shaw, Ebeling, Nguyen, Rodda, Thummel, Thacher, Hakonarson, Levine (bib25) 2018; 128 Tanaka, Wichmann, Paaren, Schnoes, DeLuca (bib10) 1980; 77 Nesterova, Malicdan, Yasuda, Sakaki, Vilboux, Ciccone, Horst, Huang, Golas, Introne, Huizing, Adams, Boerkoel, Collins, Gahl (bib3) 2013; 8 Chatterjee (10.1016/j.jbc.2021.100668_bib30) 2005; 400 Masuda (10.1016/j.jbc.2021.100668_bib12) 2005; 146 Kusudo (10.1016/j.jbc.2021.100668_bib6) 2004; 321 Kaufmann (10.1016/j.jbc.2021.100668_bib14) 2015; 156 Tanaka (10.1016/j.jbc.2021.100668_bib10) 1980; 77 Nishikawa (10.1016/j.jbc.2021.100668_bib17) 2020; 10 Ishizuka (10.1016/j.jbc.2021.100668_bib23) 1987; 262 Higashi (10.1016/j.jbc.2021.100668_bib20) 2001; 24 Kaufmann (10.1016/j.jbc.2021.100668_bib13) 2019; 188 Sakaki (10.1016/j.jbc.2021.100668_bib5) 2000; 267 Pedersen (10.1016/j.jbc.2021.100668_bib7) 1988; 250 Nesterova (10.1016/j.jbc.2021.100668_bib3) 2013; 8 Wang (10.1016/j.jbc.2021.100668_bib28) 2014; 155 Prosser (10.1016/j.jbc.2021.100668_bib8) 2007; 104 Kaufmann (10.1016/j.jbc.2021.100668_bib16) 2014; 99 Sakaki (10.1016/j.jbc.2021.100668_bib2) 2005; 10 Bouillon (10.1016/j.jbc.2021.100668_bib22) 1995; 16 Matsunaga (10.1016/j.jbc.2021.100668_bib24) 2005; 28 Roizen (10.1016/j.jbc.2021.100668_bib25) 2018; 128 Qin (10.1016/j.jbc.2021.100668_bib29) 2019; 9 Kaufmann (10.1016/j.jbc.2021.100668_bib15) 2017; 32 Wong (10.1016/j.jbc.2021.100668_bib27) 2018; 46 St-Arnaud (10.1016/j.jbc.2021.100668_bib32) 2000; 141 Schlingmann (10.1016/j.jbc.2021.100668_bib4) 2011; 365 Napoli (10.1016/j.jbc.2021.100668_bib9) 1982; 257 Nishikawa (10.1016/j.jbc.2021.100668_bib11) 2019; 185 Yasuda (10.1016/j.jbc.2021.100668_bib34) 2018; 178 Tieu (10.1016/j.jbc.2021.100668_bib35) 2014; 281 Kawagoe (10.1016/j.jbc.2021.100668_bib33) 2019; 186 Ishizuka (10.1016/j.jbc.2021.100668_bib18) 1982; 139 Pronicka (10.1016/j.jbc.2021.100668_bib31) 2017; 58 Jones (10.1016/j.jbc.2021.100668_bib1) 2012; 523 Ishizuka (10.1016/j.jbc.2021.100668_bib19) 1981; 134 St-Arnaud (10.1016/j.jbc.2021.100668_bib21) 1999; 25 Ishizuka (10.1016/j.jbc.2021.100668_bib26) 1986; 25 |
References_xml | – volume: 28 start-page: 646 year: 2005 end-page: 651 ident: bib24 article-title: Effective NADH-dependent oxidation of 7beta-hydroxy-delta8-tetrahydrocannabinol to the corresponding ketone by Japanese monkey hepatic microsomes publication-title: Biol. Pharm. Bull. contributor: fullname: Yamamoto – volume: 257 start-page: 9634 year: 1982 end-page: 9639 ident: bib9 article-title: 23S,25-dihydroxyvitamin D3 as a circulating metabolite of vitamin D3. Its role in 25-hydroxyvitamin D3-26,23-lactone biosynthesis publication-title: J. Biol. Chem. contributor: fullname: Horst – volume: 99 start-page: 2567 year: 2014 end-page: 2574 ident: bib16 article-title: Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD publication-title: J. Clin. Endocrinol. Metab. contributor: fullname: Jones – volume: 156 start-page: 4388 year: 2015 end-page: 4397 ident: bib14 article-title: A high-calcium and phosphate rescue diet and VDR-expressing transgenes normalize serum vitamin D metabolite profiles and renal Cyp27b1 and Cyp24a1 expression in VDR null mice publication-title: Endocrinology contributor: fullname: Jones – volume: 32 start-page: 1589 year: 2017 end-page: 1596 ident: bib15 article-title: Improved screening test for idiopathic infantile hypercalcemia confirms residual levels of serum 24,25-(OH)2 D3 in affected patients publication-title: J. Bone Miner. Res. contributor: fullname: Jones – volume: 46 start-page: 367 year: 2018 end-page: 379 ident: bib27 article-title: Polymorphic human sulfotransferase 2A1 mediates the formation of 25-hydroxyvitamin D3-3-O-sulfate, a major circulating vitamin D metabolite in humans publication-title: Drug Metab. Dispos. contributor: fullname: de Boer – volume: 185 start-page: 71 year: 2019 end-page: 79 ident: bib11 article-title: Generation of 1,25-dihydroxyvitamin D3 in Cyp27b1 knockout mice by treatment with 25-hydroxyvitamin D3 rescued their rachitic phenotypes publication-title: J. Steroid Biochem. Mol. Biol. contributor: fullname: Sakaki – volume: 10 start-page: 5677 year: 2020 ident: bib17 article-title: Generation of novel genetically modified rats to reveal the molecular mechanisms of vitamin D actions publication-title: Sci. Rep. contributor: fullname: Sakaki – volume: 188 start-page: 23 year: 2019 end-page: 28 ident: bib13 article-title: Calcioic acid: publication-title: J. Steroid Biochem. Mol. Biol. contributor: fullname: Jones – volume: 25 start-page: 505 year: 1986 end-page: 510 ident: bib26 article-title: The difference of biological activity among four diastereoisomers of 1α,25-dihydroxycholecalciferol-26,23-lactone publication-title: J. Steroid Biochem. contributor: fullname: Norman – volume: 10 start-page: 119 year: 2005 end-page: 134 ident: bib2 article-title: Metabolism of vitamin D3 by cytochromes P450 publication-title: Front. Biosci. contributor: fullname: Inouye – volume: 141 start-page: 2658 year: 2000 end-page: 2666 ident: bib32 article-title: Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D publication-title: Endocrinology contributor: fullname: Glorieux – volume: 267 start-page: 6158 year: 2000 end-page: 6165 ident: bib5 article-title: Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24 publication-title: Eur. J. Biochem. contributor: fullname: Inouye – volume: 281 start-page: 3280 year: 2014 end-page: 3296 ident: bib35 article-title: Kinetic analysis of human CYP24A1 metabolism of vitamin D via the C24-oxidation pathway publication-title: FEBS J. contributor: fullname: Tuckey – volume: 155 start-page: 2052 year: 2014 end-page: 2063 ident: bib28 article-title: Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: Metabolite structure, kinetics, inducibility, and interindividual variability publication-title: Endocrinology contributor: fullname: Thummel – volume: 16 start-page: 200 year: 1995 end-page: 257 ident: bib22 article-title: Structure-function relationships in the vitamin D endocrine system publication-title: Endocr. Rev. contributor: fullname: Norman – volume: 321 start-page: 774 year: 2004 end-page: 782 ident: bib6 article-title: Metabolism of A-ring diastereomers of 1α,25-dihydroxyvitamin D3 by CYP24A1 publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Inouye – volume: 186 start-page: 161 year: 2019 end-page: 168 ident: bib33 article-title: Concise synthesis of 23-hydroxylated vitamin D3 metabolites publication-title: J. Steroid Biochem. Mol. Biol. contributor: fullname: Kittaka – volume: 523 start-page: 9 year: 2012 end-page: 18 ident: bib1 article-title: 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D publication-title: Arch. Biochem. Biophys. contributor: fullname: Kaufmann – volume: 25 start-page: 127 year: 1999 end-page: 129 ident: bib21 article-title: Targeted inactivation of vitamin D hydroxylases in mice publication-title: Bone contributor: fullname: St-Arnaud – volume: 365 start-page: 410 year: 2011 end-page: 421 ident: bib4 article-title: Mutations in CYP24A1 and idiopathic infantile hypercalcemia publication-title: N. Engl. J. Med. contributor: fullname: Prosser – volume: 134 start-page: 207 year: 1981 end-page: 211 ident: bib19 article-title: Stereochemistry of 25-hydroxyvitamin D3-26,23-lactone and 1α, 25-dihydroxyvitamin D3-26,23-lactone in rat serum publication-title: FEBS Lett. contributor: fullname: Takayama – volume: 104 start-page: 12673 year: 2007 end-page: 12678 ident: bib8 article-title: Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1α,25-(OH)2D3-26,23-lactone publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: Jones – volume: 8 start-page: 649 year: 2013 end-page: 657 ident: bib3 article-title: 1,25-(OH)2D-24 hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis publication-title: Clin. J. Am. Soc. Nephrol. contributor: fullname: Gahl – volume: 146 start-page: 825 year: 2005 end-page: 834 ident: bib12 article-title: Altered pharmacokinetics of 1α,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse publication-title: Endocrinology contributor: fullname: Jones – volume: 58 start-page: 349 year: 2017 end-page: 353 ident: bib31 article-title: Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: Molecular study of 11 historical IIH cases publication-title: J. Appl. Genet. contributor: fullname: Litwin – volume: 24 start-page: 738 year: 2001 end-page: 743 ident: bib20 article-title: Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent publication-title: Biol. Pharm. Bull. contributor: fullname: Shimada – volume: 400 start-page: 165 year: 2005 end-page: 191 ident: bib30 article-title: Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1 publication-title: Methods Enzymol. contributor: fullname: Song – volume: 250 start-page: 527 year: 1988 end-page: 532 ident: bib7 article-title: Assay and properties of 25-hydroxyvitamin D3 23-hydroxylase. Evidence that 23,25-dihydroxyvitamin D3 is a major metabolite in 1,25-dihydroxyvitamin D3-treated or fasted Guinea pigs publication-title: Biochem. J. contributor: fullname: Bjorkhem – volume: 139 start-page: 267 year: 1982 end-page: 270 ident: bib18 article-title: Biological activity assessment of 25-hydroxyvitamin D3-26,23-lactone in the rat publication-title: FEBS Lett. contributor: fullname: Norman – volume: 128 start-page: 1913 year: 2018 end-page: 1918 ident: bib25 article-title: CYP3A4 mutation causes vitamin D-dependent rickets type 3 publication-title: J. Clin. Invest. contributor: fullname: Levine – volume: 9 start-page: 1087 year: 2019 end-page: 1098 ident: bib29 article-title: Role of vitamin D receptor in the regulation of CYP3A gene expression publication-title: Acta Pharm. Sin. B contributor: fullname: Wang – volume: 77 start-page: 6411 year: 1980 end-page: 6414 ident: bib10 article-title: Role of kidney tissue in the production of 25-hydroxyvitamin D3-26,23-lactone and 1α,25-dihydroxyvitamin D3-26,23-lactone publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: DeLuca – volume: 178 start-page: 333 year: 2018 end-page: 339 ident: bib34 article-title: Metabolism of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D3 by CYP24A1 and biological activity of its 24 publication-title: J. Steroid Biochem. Mol. Biol. contributor: fullname: Sakaki – volume: 262 start-page: 7165 year: 1987 end-page: 7170 ident: bib23 article-title: Metabolic pathways from 1α,25-dihydroxyvitamin D3 to 1α,25-dihydroxyvitamin D3-26,23-lactone. Stereo-retained and stereo-selective lactonization publication-title: J. Biol. Chem. contributor: fullname: Norman – volume: 139 start-page: 267 year: 1982 ident: 10.1016/j.jbc.2021.100668_bib18 article-title: Biological activity assessment of 25-hydroxyvitamin D3-26,23-lactone in the rat publication-title: FEBS Lett. doi: 10.1016/0014-5793(82)80867-3 contributor: fullname: Ishizuka – volume: 10 start-page: 119 year: 2005 ident: 10.1016/j.jbc.2021.100668_bib2 article-title: Metabolism of vitamin D3 by cytochromes P450 publication-title: Front. Biosci. contributor: fullname: Sakaki – volume: 25 start-page: 127 year: 1999 ident: 10.1016/j.jbc.2021.100668_bib21 article-title: Targeted inactivation of vitamin D hydroxylases in mice publication-title: Bone doi: 10.1016/S8756-3282(99)00118-0 contributor: fullname: St-Arnaud – volume: 141 start-page: 2658 year: 2000 ident: 10.1016/j.jbc.2021.100668_bib32 article-title: Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D publication-title: Endocrinology doi: 10.1210/endo.141.7.7579 contributor: fullname: St-Arnaud – volume: 523 start-page: 9 year: 2012 ident: 10.1016/j.jbc.2021.100668_bib1 article-title: 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D publication-title: Arch. Biochem. Biophys. doi: 10.1016/j.abb.2011.11.003 contributor: fullname: Jones – volume: 25 start-page: 505 year: 1986 ident: 10.1016/j.jbc.2021.100668_bib26 article-title: The difference of biological activity among four diastereoisomers of 1α,25-dihydroxycholecalciferol-26,23-lactone publication-title: J. Steroid Biochem. doi: 10.1016/0022-4731(86)90395-X contributor: fullname: Ishizuka – volume: 185 start-page: 71 year: 2019 ident: 10.1016/j.jbc.2021.100668_bib11 article-title: Generation of 1,25-dihydroxyvitamin D3 in Cyp27b1 knockout mice by treatment with 25-hydroxyvitamin D3 rescued their rachitic phenotypes publication-title: J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2018.07.012 contributor: fullname: Nishikawa – volume: 281 start-page: 3280 year: 2014 ident: 10.1016/j.jbc.2021.100668_bib35 article-title: Kinetic analysis of human CYP24A1 metabolism of vitamin D via the C24-oxidation pathway publication-title: FEBS J. doi: 10.1111/febs.12862 contributor: fullname: Tieu – volume: 104 start-page: 12673 year: 2007 ident: 10.1016/j.jbc.2021.100668_bib8 article-title: Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1α,25-(OH)2D3-26,23-lactone publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0702093104 contributor: fullname: Prosser – volume: 134 start-page: 207 year: 1981 ident: 10.1016/j.jbc.2021.100668_bib19 article-title: Stereochemistry of 25-hydroxyvitamin D3-26,23-lactone and 1α, 25-dihydroxyvitamin D3-26,23-lactone in rat serum publication-title: FEBS Lett. doi: 10.1016/0014-5793(81)80603-5 contributor: fullname: Ishizuka – volume: 58 start-page: 349 year: 2017 ident: 10.1016/j.jbc.2021.100668_bib31 article-title: Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: Molecular study of 11 historical IIH cases publication-title: J. Appl. Genet. doi: 10.1007/s13353-017-0397-2 contributor: fullname: Pronicka – volume: 267 start-page: 6158 year: 2000 ident: 10.1016/j.jbc.2021.100668_bib5 article-title: Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24 publication-title: Eur. J. Biochem. doi: 10.1046/j.1432-1327.2000.01680.x contributor: fullname: Sakaki – volume: 28 start-page: 646 year: 2005 ident: 10.1016/j.jbc.2021.100668_bib24 article-title: Effective NADH-dependent oxidation of 7beta-hydroxy-delta8-tetrahydrocannabinol to the corresponding ketone by Japanese monkey hepatic microsomes publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.28.646 contributor: fullname: Matsunaga – volume: 8 start-page: 649 year: 2013 ident: 10.1016/j.jbc.2021.100668_bib3 article-title: 1,25-(OH)2D-24 hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis publication-title: Clin. J. Am. Soc. Nephrol. doi: 10.2215/CJN.05360512 contributor: fullname: Nesterova – volume: 365 start-page: 410 year: 2011 ident: 10.1016/j.jbc.2021.100668_bib4 article-title: Mutations in CYP24A1 and idiopathic infantile hypercalcemia publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1103864 contributor: fullname: Schlingmann – volume: 178 start-page: 333 year: 2018 ident: 10.1016/j.jbc.2021.100668_bib34 article-title: Metabolism of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D3 by CYP24A1 and biological activity of its 24R-hydroxylated metabolite publication-title: J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2018.02.001 contributor: fullname: Yasuda – volume: 250 start-page: 527 year: 1988 ident: 10.1016/j.jbc.2021.100668_bib7 article-title: Assay and properties of 25-hydroxyvitamin D3 23-hydroxylase. Evidence that 23,25-dihydroxyvitamin D3 is a major metabolite in 1,25-dihydroxyvitamin D3-treated or fasted Guinea pigs publication-title: Biochem. J. doi: 10.1042/bj2500527 contributor: fullname: Pedersen – volume: 400 start-page: 165 year: 2005 ident: 10.1016/j.jbc.2021.100668_bib30 article-title: Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1 publication-title: Methods Enzymol. doi: 10.1016/S0076-6879(05)00010-8 contributor: fullname: Chatterjee – volume: 24 start-page: 738 year: 2001 ident: 10.1016/j.jbc.2021.100668_bib20 article-title: Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.24.738 contributor: fullname: Higashi – volume: 186 start-page: 161 year: 2019 ident: 10.1016/j.jbc.2021.100668_bib33 article-title: Concise synthesis of 23-hydroxylated vitamin D3 metabolites publication-title: J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2018.10.010 contributor: fullname: Kawagoe – volume: 257 start-page: 9634 year: 1982 ident: 10.1016/j.jbc.2021.100668_bib9 article-title: 23S,25-dihydroxyvitamin D3 as a circulating metabolite of vitamin D3. Its role in 25-hydroxyvitamin D3-26,23-lactone biosynthesis publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)34119-X contributor: fullname: Napoli – volume: 128 start-page: 1913 year: 2018 ident: 10.1016/j.jbc.2021.100668_bib25 article-title: CYP3A4 mutation causes vitamin D-dependent rickets type 3 publication-title: J. Clin. Invest. doi: 10.1172/JCI98680 contributor: fullname: Roizen – volume: 146 start-page: 825 year: 2005 ident: 10.1016/j.jbc.2021.100668_bib12 article-title: Altered pharmacokinetics of 1α,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse publication-title: Endocrinology doi: 10.1210/en.2004-1116 contributor: fullname: Masuda – volume: 156 start-page: 4388 year: 2015 ident: 10.1016/j.jbc.2021.100668_bib14 article-title: A high-calcium and phosphate rescue diet and VDR-expressing transgenes normalize serum vitamin D metabolite profiles and renal Cyp27b1 and Cyp24a1 expression in VDR null mice publication-title: Endocrinology doi: 10.1210/en.2015-1664 contributor: fullname: Kaufmann – volume: 99 start-page: 2567 year: 2014 ident: 10.1016/j.jbc.2021.100668_bib16 article-title: Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2013-4388 contributor: fullname: Kaufmann – volume: 9 start-page: 1087 year: 2019 ident: 10.1016/j.jbc.2021.100668_bib29 article-title: Role of vitamin D receptor in the regulation of CYP3A gene expression publication-title: Acta Pharm. Sin. B doi: 10.1016/j.apsb.2019.03.005 contributor: fullname: Qin – volume: 77 start-page: 6411 year: 1980 ident: 10.1016/j.jbc.2021.100668_bib10 article-title: Role of kidney tissue in the production of 25-hydroxyvitamin D3-26,23-lactone and 1α,25-dihydroxyvitamin D3-26,23-lactone publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.77.11.6411 contributor: fullname: Tanaka – volume: 10 start-page: 5677 year: 2020 ident: 10.1016/j.jbc.2021.100668_bib17 article-title: Generation of novel genetically modified rats to reveal the molecular mechanisms of vitamin D actions publication-title: Sci. Rep. doi: 10.1038/s41598-020-62048-1 contributor: fullname: Nishikawa – volume: 188 start-page: 23 year: 2019 ident: 10.1016/j.jbc.2021.100668_bib13 article-title: Calcioic acid: In vivo detection and quantification of the terminal C24-oxidation product of 25-hydroxyvitamin D3 and related intermediates in serum of mice treated with 24,25-dihydroxyvitamin D3 publication-title: J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2018.12.001 contributor: fullname: Kaufmann – volume: 46 start-page: 367 year: 2018 ident: 10.1016/j.jbc.2021.100668_bib27 article-title: Polymorphic human sulfotransferase 2A1 mediates the formation of 25-hydroxyvitamin D3-3-O-sulfate, a major circulating vitamin D metabolite in humans publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.117.078428 contributor: fullname: Wong – volume: 155 start-page: 2052 year: 2014 ident: 10.1016/j.jbc.2021.100668_bib28 article-title: Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: Metabolite structure, kinetics, inducibility, and interindividual variability publication-title: Endocrinology doi: 10.1210/en.2013-2013 contributor: fullname: Wang – volume: 262 start-page: 7165 year: 1987 ident: 10.1016/j.jbc.2021.100668_bib23 article-title: Metabolic pathways from 1α,25-dihydroxyvitamin D3 to 1α,25-dihydroxyvitamin D3-26,23-lactone. Stereo-retained and stereo-selective lactonization publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)48219-1 contributor: fullname: Ishizuka – volume: 32 start-page: 1589 year: 2017 ident: 10.1016/j.jbc.2021.100668_bib15 article-title: Improved screening test for idiopathic infantile hypercalcemia confirms residual levels of serum 24,25-(OH)2 D3 in affected patients publication-title: J. Bone Miner. Res. doi: 10.1002/jbmr.3135 contributor: fullname: Kaufmann – volume: 321 start-page: 774 year: 2004 ident: 10.1016/j.jbc.2021.100668_bib6 article-title: Metabolism of A-ring diastereomers of 1α,25-dihydroxyvitamin D3 by CYP24A1 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2004.07.040 contributor: fullname: Kusudo – volume: 16 start-page: 200 year: 1995 ident: 10.1016/j.jbc.2021.100668_bib22 article-title: Structure-function relationships in the vitamin D endocrine system publication-title: Endocr. Rev. contributor: fullname: Bouillon |
SSID | ssj0000491 |
Score | 2.4688451 |
Snippet | CYP24A1-deficient (Cyp24a1 KO) rats were generated using the CRISPER/Cas9 system to investigate CYP24A1-dependent or -independent metabolism of 25(OH)D3, the... CYP24A1-deficient ( Cyp24a1 KO) rats were generated using the CRISPER/Cas9 system to investigate CYP24A1-dependent or -independent metabolism of 25(OH)D3, the... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 100668 |
SubjectTerms | CRISPR/Cas9 CYP24A1 cytochrome P450 metabolism vitamin D |
Title | Elucidation of metabolic pathways of 25-hydroxyvitamin D3 mediated by CYP24A1 and CYP3A using Cyp24a1 knockout rats generated by CRISPR/Cas9 system |
URI | https://dx.doi.org/10.1016/j.jbc.2021.100668 https://www.ncbi.nlm.nih.gov/pubmed/33865853 https://search.proquest.com/docview/2515064690 https://pubmed.ncbi.nlm.nih.gov/PMC8134072 |
Volume | 296 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLXabmCDoOUxPCojIRZI6Uz8SrwchVYFVDQUKpVVZN84bcrEM2IyoHwHP4ztjCsKggWbKEpiydK59j2xj89F6EWuzCSTqnLMTULiMrRIpErrhPLKkQ3NtRD-gPPJe3F8xt6e8_MtxONZmCDaB90c2Hl7YJvLoK1ctjCOOrHx7KTIU-p9vcbbaNsFaPxFj9Mv25TJ89oDwvO4lRlEXVfa2xaS1IsDhPDF-qgveplz-re89Cfv_F0--Us-OrqL7myIJJ4OHb6HtozdRXtT636i2x6_xEHaGdbMd9GtIpZ120M_DudraIZKSnhR49Z0Lg7mDWBfnPi76lf-KeHJZV95icu3plNtY_FrisMpE8dQse5x8XlG2DTFylb-nk6xV9Bf4KJfEqZS_MW6iXax7rCLsBW-CObWsenpm4-z03GhVhIPRtL30dnR4afiONlUZkiAp1mXGEMoM0oAGK4MZJRoLTSkQKiuMg2mdgM7d-QqVzVlACIDXhPmuDHLYJIr-gDt2IU1jxBmUGUAmmRSOKZR1VrqWoJUmgOVFZARehVxKZeDAUcZlWlXpcOz9HiWA54jxCJy5YZBDMygdAniX82eR5RLh4bfMlHWLNar0rE_7-gn5GSEHg6oX_ciRs4IZTfi4foD79x9840L6ODgvQngx__d8gm67fs_rAU9RTvd17V55thRp_fDqoK7vvuQ74eR8ROVBBEd |
link.rule.ids | 230,315,730,783,787,867,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXGeBgvCDZgHV9GQjwgZW38lfixCps6WKdqbNJ4iuwbZ8to0mpNQfkd_GHsJJ4YCB54i5JYcnSufY_j43MRehsrM4qkyixzkxDYDC0CqcI8oDyzZENzLYQ74Dw9EZNz9vGCX2wg7s_CtKJ90MV-NS_3q-Kq1VYuSxh6ndhwNk3ikDpfr-E9dN-O1xHzi3Q_AbO-UJ5THxAe-83MVtZ1rZ1xIQmdPEAIV66PurKXMad_y0x_Ms_fBZS_ZKTDR-hhTyXxuOvyY7Rhqm20M67sMrps8Dvcijvbv-bbaCvxhd120I-D-RqKrpYSXuS4NLWNhHkB2JUn_q6albtLeHDVZE7k8q2oVVlU-APF7TkTy1GxbnDyZUbYOMSqytw1HWOnob_ESbMkTIX4a2Wn2sW6xjbGVviytbf2TU-PPs9Oh4laSdxZST9B54cHZ8kk6GszBMDDqA6MIZQZJQAMVwYiSrQWGkIgVGeRBpPboR1behWrnDIAEQHPCbPsmEUwihV9ijarRWV2EWaQRQCaRFJYrpHlWupcglSaA5UZkAF673FJl50FR-q1adepxTN1eKYdngPEPHJpzyE6bpDaFPGvZm88yqlFw22aqMos1qvU8j_n6SfkaICedajf9sJHzgBFd-Lh9gXn3X33iQ3p1sO7D-G9_275Gm1NzqbH6fHRyafn6IH7lu7P0Au0Wd-szUvLlWr9qh0ZPwE8nhKJ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWgSMAGQctjystIiAVSmolfiZejtKMWaDUqVCqryL5x2pRJZtTJgPId_DB2ElctCBbsoiSWHJ1r3-P4-FyE3ibKjGOpcsvcJAQ2Q4tAqqgIKM8t2dBcC-EOOB8eif0T9uGUn14r9dWJ9kGXO_W82qnL805buawg9DqxcHaYJhF1vl7hMi_C2-iOHbNj4RfqfhJmQ7E8p0AgPPEbmp2060I780ISOYmAEK5kH3WlLxNO_5ad_mSfv4sor2Wl6UP0YKCTeNJ3-xG6ZepNtDWp7VK6avE73Ak8uz_nm-he6ou7baGfe_M1lH09JbwocGUaGw3zErArUfxDtSt3l_DgvM2d0OV72aiqrPEuxd1ZE8tTsW5x-nVG2CTCqs7dNZ1gp6M_w2m7JExF-Fttp9vFusE2zlb4rLO49k2PDz7PjsNUrSTu7aQfo5Pp3pd0PxjqMwTAo7gJjCGUGSUADFcGYkq0FhoiIFTnsQZT2OGdWIqVqIIyABEDLwizDJnFME4UfYI26kVtniHMII8BNImlsHwjL7TUhQSpNAcqcyAj9N7jki17G47M69MuMotn5vDMejxHiHnksoFH9Pwgs2niX83eeJQzi4bbOFG1WaxXmeWAztdPyPEIPe1Rv-qFj5wRim_Ew9ULzr_75hMb1p2P9xDG2__d8jW6O9udZp8Ojj4-R_fdp_Q_h16gjeZybV5autToV93A-AUowROc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elucidation+of+metabolic+pathways+of+25-hydroxyvitamin+D3+mediated+by+CYP24A1+and+CYP3A+using+Cyp24a1+knockout+rats+generated+by+CRISPR%2FCas9+system&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Yasuda%2C+Kaori&rft.au=Nishikawa%2C+Miyu&rft.au=Okamoto%2C+Kairi&rft.au=Horibe%2C+Kyohei&rft.date=2021-01-01&rft.eissn=1083-351X&rft.volume=296&rft.spage=100668&rft.epage=100668&rft_id=info:doi/10.1016%2Fj.jbc.2021.100668&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon |